BMY vs ROP · P/E 17, rev $24.46B vs P/E 41, rev $4.20B
Bristol-Myers Squibb Company (BMY) versus Roper Technologies, Inc. (ROP) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Chris Boerner.
Roper Technologies, Inc. (ROP) is a software - application company listed on US.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported ROP revenue for 2026-06-30 was $4.20B. Net income was $1.68B. ROP currently screens at market cap $61.61B and trailing P/E 41.3.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. ROP currently screens at market cap $61.61B and trailing P/E 41.3.
Not investment advice. Open the BMY and ROP stock pages for the full models.
Not investment advice.